Zobrazeno 1 - 10
of 218
pro vyhledávání: '"Fluticasone furoate/vilanterol"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Furuhashi K, Fujisawa T, Hashimoto D, Kamiya Y, Yasui H, Karayama M, Suzuki Y, Hozumi H, Enomoto N, Nakamura Y, Inui N, Suda T
Publikováno v:
Journal of Asthma and Allergy, Vol Volume 12, Pp 253-261 (2019)
Kazuki Furuhashi,1,2 Tomoyuki Fujisawa,1 Dai Hashimoto,3 Yousuke Kamiya,1 Hideki Yasui,1 Masato Karayama,1 Yuzo Suzuki,1 Hironao Hozumi,1 Noriyuki Enomoto,1 Yutaro Nakamura,1 Naoki Inui,1,4 Takafumi Suda1 1Second Division, Department of Internal Medi
Externí odkaz:
https://doaj.org/article/1997f4beeb1c48cca302fd90a4825be2
Autor:
Daniel Dedman, Sonia J. Coton, Rebecca E. Ghosh, Wilhelmine Meeraus, Courtney Crim, Catherine Harvey, Justyna Amelio, Sarah H. Landis
Publikováno v:
Pulmonary Therapy, Vol 5, Iss 1, Pp 81-95 (2019)
Abstract Introduction This retrospective database study explored treatment patterns and potential off-label prescribing among patients newly prescribed fluticasone furoate/vilanterol (FF/VI) in a UK primary care setting. Methods In Europe, FF/VI is a
Externí odkaz:
https://doaj.org/article/57f6935a3d7b49bf92e1fd4367328780
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol Volume 10, Pp 501-510 (2018)
Laura Amanda Vallejo-Aparicio,1 Germán Peces-Barba,2 Alicia Gil,3 Alicia Huerta Hernandez1 1Market Access, GlaxoSmithKline, Tres Cantos, Madrid, Spain; 2IIS-Fundación Jiménez Díaz. CIBERES, Madrid, Spain; 3Omakase Consulting, Barcelona, Spain Obj
Externí odkaz:
https://doaj.org/article/889769b8503443a88decea1fe6d72e1a
Publikováno v:
Multidisciplinary Respiratory Medicine, Vol 13, Iss 1, Pp 1-11 (2018)
Abstract Background Bronchial asthma is an inflammatory disease of the airways. Beclomethasone dipropionate/Formoterol (BDP/F) and Fluticasone furoate/Vilanterol (FF/V) are two of the most effective LABA/ICS combinations for managing persistent bronc
Externí odkaz:
https://doaj.org/article/4264f6f8d69f48fb81b5e9f796ad334e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Drug Design, Development and Therapy, Vol Volume 10, Pp 4047-4060 (2016)
Timothy E Albertson,1–3 Samuel W Bullick,1,3 Michael Schivo,1 Mark E Sutter2,3 1Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, 2Department of Emergency Medicine, School of Medicine, UC Davis, Sacramento, 3
Externí odkaz:
https://doaj.org/article/0a40549c9dde4370802cd3aecd73c58f
Autor:
Courtney Crim, David M. Mannino, Lee Tombs, Scott Caveney, Hitesh Patel, Sally Lettis, Nicola A. Hanania, Isabelle Boucot, Tedi Soule
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease
Nicola A Hanania,1 Scott Caveney,2 Tedi Soule,2 Lee Tombs,3 Sally Lettis,4 Courtney Crim,5,6 David M Mannino,7 Hitesh Patel,2 Isabelle H Boucot4 1Airways Clinical Research Center, Section of Pulmonary and Critical Care Medicine, Baylor College of Med
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::484295857868626904f535c6bef069cf
https://doi.org/10.2147/copd.s302864
https://doi.org/10.2147/copd.s302864
Publikováno v:
International Journal of COPD, Vol 2016, Iss default, Pp 1-12 (2015)
Henry Covelli,1 Bonavuth Pek,2 Isabelle Schenkenberger,3 Catherine Scott-Wilson,4 Amanda Emmett,5 Courtney Crim4 1Kootenai Health, Coeur d’Alene, ID, USA; 2Clinique de Pneumologie et de Sommeil de Lanaudière, Quebec, Canada; 3Klinische Forschung,
Externí odkaz:
https://doaj.org/article/0d82294a1f5a47a2894cded680c8ad1a
Autor:
Ronen Bar-Yoseph, Shalev Zuckerman, Kamal Masarweh, Yazeed Toukan, Vered Nir, Guy Gut, Moneera Hanna, Michal Gur, Lea Bentur
Publikováno v:
Basic & Clinical Pharmacology & Toxicology. 129:369-375
PURPOSE Relvar® (fluticasone furoate [FF]/vilanterol [VI]) is a once-daily inhaler with bronchodilator effect lasting 24 h. Our aim was to investigate the short- and long-term effects of FF/VI on exercise-induced asthma (EIA) in adolescents. METHODS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b81267e026fb8d108d56f9449685747
https://doi.org/10.1111/bcpt.13640
https://doi.org/10.1111/bcpt.13640